HRTX Exercise Disclosure
Duarte Ira · SEC Form 4 · Filed Oct 21, 2026
Exercise
Reported value range
Not reported
Duarte Ira EVP, Chief Financial Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Oct 19, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 2 days later
HRTX daily price context
Close on/before transaction
$0.36
Oct 19, 2026
First close after public filing
$0.34
Oct 21, 2026
Return after filing · so far
+10.6%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,874 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-427545
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$396.72
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 19, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX | Disposition | Oct 19, 2026 | $396.72 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Exercise | Oct 19, 2026 | Not reported |